Women's Health Initiative results: A glass more empty than full

Fertility and Sterility

Volumn 80, Issue 3, 2003, Pages 488-490

  Strickler, Ronald C ^a,b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Hormone therapy; Menopause; Women's Health Initiative

Indexed keywords

BREAST CARCINOMA; DATA ANALYSIS; DRUG SAFETY; FEMALE; HEALTH; HUMAN; MEDICAL LITERATURE; MEDICAL SPECIALIST; MONITORING; PRIORITY JOURNAL; SHORT SURVEY; STATISTICAL PARAMETERS; STATISTICAL SIGNIFICANCE; STATISTICS;

EID: 0042232349     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)00994-4     Document Type: Note

References (9)

1. Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the Women's Health Initiative randomized controlled trial. JAMA. 288:2002;321-323.
2. Bush T.L., Whiteman M., Flaws J.A. Hormone replacement therapy and breast cancer a qualitative analysis. Obstet Gynecol. 98:2001;498-508.
3. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 280:1998;605-613.
4. Mikkola T.S., Clarkson T.B. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res. 53:2002;605-619.
5. Hodis H.J., Mack W.J., Lobo R.A., Shoupe D., Sevanian A., Mahrer P.R., et al. Estrogen in the prevention of atherosclerosis. Ann Intern Med. 135:2001;939-953.
6. Herrington D.M., Reboussin D.M., Brosnihan K.B., Sharp P.C., Shumaker S.A., Snyder T.E., et al. Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N Engl J Med. 343:2000;522-529.
7. Kronenberg F. Hot flashes epidemiology and physiology. Ann NY Acad Sci. 592:1990;52-86.
8. Breast cancer and hormone replacement therapy collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet. 350:1997;1047-1059.
9. Castellsague J., Perez Gutthann S., Garcia Rodrigues L.A. Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism a review. Drug Saf. 18:1998;117-123.